RoukenBio
PrivateLast Round
Private Equity
Nov 2, 2023
Total Funding Raised
$710,000
Company Overview
RoukenBio operates in Healthcare & Life Sciences and is based in Motherwell. Its latest recorded funding round was a Private Equity round in November 2023.
RoukenBio is a biotechnology company that provides immunology-centered contract research organization (CRO) services for biopharmaceutical and drug development companies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RoukenBio Comparables
Compare RoukenBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellomatics Biosciences | 82% | |
| Concept Life Sciences | 81% | |
| InnoSer Nederland | 78% |
For institutional investors. Book with your work email.
RoukenBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Nov 2, 2023 | ||||
| Grant | Dec 1, 2020 | ||||
| Grant | Aug 4, 2020 | ||||
| VC Round | Jun 3, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RoukenBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NorthEdge Capital | Private Equity |
| Innovate UK | Grant |
| UK Steel Enterprise | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 80% MoM, reaching 10K.
- Dec 1, 2020
$270K grant received from Innovate UK.
For institutional investors. Book with your work email.
RoukenBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RoukenBio's valuation, stock price, and market status.
Is RoukenBio a public or private company?
RoukenBio is a private company.
What is the current stock price of RoukenBio?
RoukenBio is a private company, so its shares have no public market price. Caplight tracks RoukenBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RoukenBio worth (valuation)?
Valuation information for RoukenBio is not publicly available.
Can I buy RoukenBio stock?
RoukenBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RoukenBio's last funding round?
RoukenBio's most recent funding round was Private Equity on November 2, 2023.
Who are the main investors in RoukenBio?
Key investors in RoukenBio include NorthEdge Capital, UK Steel Enterprise.
Will RoukenBio IPO soon?
No public IPO plans have been announced for RoukenBio.
How can I track RoukenBio secondary market activity?
Caplight tracks bids, offers, and trades in RoukenBio's shares on secondary markets.